๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab

โœ Scribed by Irit Avivi; Suparno Chakrabarti; Donald W Milligan; H Waldmann; Geoff Hale; Husam Osman; Katherine N Ward; Christopher D Fegan; Kwee Yong; Anthony H Goldstone; David C Linch; Stephen MacKinnon


Book ID
116277533
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
139 KB
Volume
10
Category
Article
ISSN
1083-8791

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Lamivudine prophylaxis and treatment of
โœ S.E. Moses; Z.Y. Lim; M. Sudhanva; S. Devereux; A.Y.L. Ho; A. Pagliuca; M. Zucke ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB

Individuals with past exposure to hepatitis B virus (HBV) may reactivate HBV following bone marrow transplantation. Alemtuzumab (CAMPATH)based reduced intensity conditioning bone marrow transplantation has been associated with a high incidence of viral infections. Lamivudine prophylaxis for HBV shou